Cystatin C as a Predictor of Major Adverse Cardiovascular Event in Patients with Acute Myocardial Infarction Without Cardiogenic Shock and Renal Impairment After Coronary Intervention

PURPOSE: To prove that cystatin C is a predictor of major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI), either with ST-segment Elevation (AMI-EST) or without ST-segment elevation (AMI-NEST), without cardiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasyanto, Trisulo, Yasa, Ahmad, Yudhistira, Yoga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246715/
https://www.ncbi.nlm.nih.gov/pubmed/37293518
http://dx.doi.org/10.2147/IJGM.S415595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246715/
https://www.ncbi.nlm.nih.gov/pubmed/37293518
http://dx.doi.org/10.2147/IJGM.S415595

Ejemplares similares